E E Voest Selected Research

indibulin

4/2010	Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors.
6/2007	Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E E Voest Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 03/2000
14	Neoplasm Metastasis (Metastasis) 02/2017 - 03/2000
5	Breast Neoplasms (Breast Cancer) 07/2011 - 06/2000
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 07/2010 - 03/2000
2	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 09/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2011
2	Neoplasm Micrometastasis 02/2017 - 03/2000
2	Carcinogenesis 01/2016 - 05/2006
2	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 11/2002
2	Neutropenia 02/2011 - 10/2008
2	Infections 10/2008 - 07/2003
2	Vomiting 06/2007 - 07/2003
2	Nausea 06/2007 - 07/2003
1	Melanoma (Melanoma, Malignant) 01/2022
1	Clinical Deterioration 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 09/2015
1	Liver Failure 09/2015
1	Hand-Foot Syndrome 09/2015
1	Adenocarcinoma 05/2015
1	Vascular Diseases (Vascular Disease) 05/2015
1	Sarcoma (Soft Tissue Sarcoma) 06/2014
1	Dysgeusia (Parageusia) 08/2013
1	Fatigue 08/2013
1	Atrial Flutter (Flutter, Atrial) 11/2011
1	Hypertension (High Blood Pressure) 11/2011
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2010
1	Catheter-Related Infections 10/2008
1	Hypothyroidism 09/2007
1	Paralysis (Palsy) 09/2007
1	Exanthema (Rash) 09/2007

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2022 - 03/2001
4	Epirubicin (Ellence)FDA LinkGeneric 05/2015 - 06/2000
4	Angiogenesis InhibitorsIBA 01/2010 - 10/2002
4	AngiostatinsIBA 01/2003 - 03/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017 - 11/2002
3	Bevacizumab (Avastin)FDA Link 02/2017 - 02/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 06/2000
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2011 - 06/2000
3	AnthracyclinesIBA 11/2006 - 06/2000
3	EndostatinsIBA 02/2005 - 10/2002
3	Biological ProductsIBA 01/2005 - 03/2000
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2003
2	Topotecan (Hycamtin)FDA LinkGeneric 09/2015 - 03/2009
2	Capecitabine (Xeloda)FDA Link 05/2015 - 02/2006
2	CP 4126IBA 08/2013 - 08/2013
2	Proteins (Proteins, Gene)FDA Link 07/2010 - 10/2005
2	indibulinIBA 04/2010 - 06/2007
2	Sorafenib (BAY 43-9006)FDA Link 01/2010 - 02/2008
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 05/2004 - 10/2003
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	VemurafenibIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	pertuzumabIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	cobimetinibIBA 01/2022
1	NivolumabIBA 10/2019
1	Everolimus FDA Link 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	LigandsIBA 01/2016
1	LipidsIBA 01/2016
1	LysophospholipidsIBA 01/2016
1	EicosanoidsIBA 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	PlatinumIBA 09/2015
1	Cisplatin (Platino)FDA LinkGeneric 05/2015
1	Gemcitabine FDA Link 08/2013
1	cabazitaxel FDA Link 04/2013
1	eribulin FDA Link 12/2012
1	Cytotoxins (Cytolysins)IBA 09/2012
1	telatinibIBA 11/2011
1	Lipase (Acid Lipase)FDA Link 11/2011
1	Tyrosine Kinase InhibitorsIBA 11/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2011
1	Aurora Kinase BIBA 02/2011
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 02/2011
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2010
1	Amyloid (Amyloid Fibrils)IBA 07/2010
1	Capsules (Microcapsules)IBA 04/2010
1	vatalanib (PTK787)IBA 11/2009
1	temsirolimus FDA Link 02/2008
1	Interleukin-2 (IL2)IBA 02/2008
1	Interferon-alpha (Interferon Alfa)IBA 02/2008
1	Sunitinib (Sutent)FDA Link 02/2008
1	Imatinib Mesylate (Gleevec)FDA Link 09/2007
1	Thyroid HormonesIBA 09/2007
1	SolutionsIBA 06/2007

Therapy/Procedure

15	Therapeutics 01/2022 - 08/2000
10	Drug Therapy (Chemotherapy) 01/2016 - 10/2002
2	Immunotherapy 10/2019 - 02/2008
2	Radiotherapy 04/2006 - 12/2004
1	Enteral Nutrition (Feeding, Tube) 01/2022
1	Aftercare (After-Treatment) 08/2009
1	Catheters 10/2008
1	Blood Component Removal (Apheresis) 10/2008
1	Central Venous Catheters 10/2008
1	Total Parenteral Nutrition 10/2008
1	Tracheotomy 09/2007
1	Thyroidectomy 09/2007